341 related articles for article (PubMed ID: 11936424)
21. [Effects of CS-866, an angiotensin II receptor antagonist, in 5/6 nephrectomized spontaneously hypertensive rats].
Xu HL; Yoshida K; Wu XM; Kohzuki M
Nihon Jinzo Gakkai Shi; 2001 Oct; 43(7):580-8. PubMed ID: 11725555
[TBL] [Abstract][Full Text] [Related]
22. Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
Haas M; de Boer E; de Jong PE; Moolenaar F; Meijer DK; de Zeeuw D
Clin Sci (Lond); 2003 Jul; 105(1):51-7. PubMed ID: 12636872
[TBL] [Abstract][Full Text] [Related]
23. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
Ricardo SD; Bertram JF; Ryan GB
Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
[TBL] [Abstract][Full Text] [Related]
24. Low molecular weight heparin in the treatment of puromycin-induced nephrosis.
Dos Santos AM; de Olveira AV; da Silva Lemos CC; Mandarim-de-Lacerda CA; Bregman R
Pathol Res Pract; 2006; 202(3):157-63. PubMed ID: 16492522
[TBL] [Abstract][Full Text] [Related]
25. Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis.
Glasser RJ; Velosa JA; Michael AF
Lab Invest; 1977 May; 36(5):519-26. PubMed ID: 865079
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms.
Tanaka R; Kon V; Yoshioka T; Ichikawa I; Fogo A
Kidney Int; 1994 Feb; 45(2):537-43. PubMed ID: 8164442
[TBL] [Abstract][Full Text] [Related]
27. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
Holthöfer H; Reivinen J; Solin ML; Haltia A; Miettinen A
Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
[TBL] [Abstract][Full Text] [Related]
28. [Effects of human Cu, Zn-superoxide dismutase in aminonucleoside nephrosis--evaluation of the morphology and glomerular basement membrane anionic charge sites].
Higuchi A
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):767-75. PubMed ID: 2273594
[TBL] [Abstract][Full Text] [Related]
29. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
Matsuda H; Hayashi K; Saruta T
J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
[TBL] [Abstract][Full Text] [Related]
30. [Effects of FK506 on aminonucleoside-induced nephrotic rats].
Kawaguchi S
Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):141-51. PubMed ID: 1375300
[TBL] [Abstract][Full Text] [Related]
31. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.
Diamond JR; Anderson S
Am J Pathol; 1990 Dec; 137(6):1323-32. PubMed ID: 2260622
[TBL] [Abstract][Full Text] [Related]
32. [A role for reactive oxygen species in the pathogenesis of focal glomerulosclerosis].
Kawamoto S; Kawamura T
Nihon Jinzo Gakkai Shi; 1996 Nov; 38(11):484-92. PubMed ID: 8958702
[TBL] [Abstract][Full Text] [Related]
33. Glomerular metalloprotease activity modulates the development of focal segmental glomerulosclerosis.
Sagar S; Gibbons N; Valderrama E; Singhal PC
Clin Nephrol; 1995 Dec; 44(6):356-61. PubMed ID: 8719546
[TBL] [Abstract][Full Text] [Related]
34. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
Yang HD; Dong C; Guan FJ; Gao LL; Zhao T; Feng BF
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862
[TBL] [Abstract][Full Text] [Related]
35. Morphologic, molecular and hemodynamic cardiac alterations in a model of nephropathy induced by puromycin aminonucleoside.
Moreira-Rodrigues M; Roncon-Albuquerque R; Henriques-Coelho T; Sampaio-Maia B; Leite-Moreira A; Pestana M
Rev Port Cardiol; 2006 May; 25(5):509-18. PubMed ID: 16910158
[TBL] [Abstract][Full Text] [Related]
36. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet.
Imai E; Takenaka M; Isaka Y; Moriyama T; Akagi Y; Kakuchi J; Fujii T; Ito T; Hori M; Horio M; Syoji T; Tsubakihara Y
Clin Exp Nephrol; 2003 Jun; 7(2):113-9. PubMed ID: 14586729
[TBL] [Abstract][Full Text] [Related]
37. [The effect of temocapril, an angiotensin-converting enzyme inhibitor with preferential biliary excretion, on experimental diabetic nephropathy].
Yanagisawa Y
Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1095-102. PubMed ID: 7815741
[TBL] [Abstract][Full Text] [Related]
38. The renal clearance of dextran sulfate decreases in puromycin aminonucleoside-induced glomerulosclerosis: a puzzle observation.
Santos AM; Pomin VH; Stelling MP; Guimarães MA; Cardoso LR; Mourão PA
Clin Chim Acta; 2007 Aug; 383(1-2):116-25. PubMed ID: 17599817
[TBL] [Abstract][Full Text] [Related]
39. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
40. Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats.
Tofovic SP; Rominski BR; Bastacky S; Jackso EK; Kost CK
Ren Fail; 2000 Mar; 22(2):159-79. PubMed ID: 10803761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
